Author Information
Marc Lipsitch is a distinguished researcher affiliated with the Center for Communicable Disease Dynamics, the Department of Epidemiology, and the Department of Immunology and Infectious Diseases at the Harvard T. H. Chan School of Public Health in Boston, MA, USA. His work primarily focuses on infectious diseases, and he has made significant contributions to the understanding and control of infectious disease dynamics.Research Contributions
Marc Lipsitch has made substantial contributions to the field of infectious diseases, particularly in the context of epidemiology and public health. In 2022, his research covered various aspects of the COVID-19 pandemic, including vaccine efficacy, clinical outcomes of SARS-CoV-2 variants, and the indirect protection offered by vaccination. His work has addressed key issues such as antibiotic prescribing patterns, real-time epidemic surveillance, and equitable vaccine prioritization. Lipsitch has also explored biases in vaccine evaluations and studied long-term clinical sequelae in older adults following infection.Aliases
Marc Lipsitch is also known by aliases such as M Lipsitch, M. Lipsitch, and Mark Lipsitch. These variations of his name are commonly used in academic publications and citations.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
49,871 |
| H-index |
114 |
| Paper Count |
557 |
